SEC Form 4 · accession 0001387131-17-001180
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert O Hopkins
Officer — Chief Financial Officer
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Mar 1, 2017 | A | 200,000 | A | — | — | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock. The RSUs vest on the seventh anniversary of the grant date provided that the Reporting Person has continued to provide services to the Company during such period. The RSUs vest earlier in connection with a Change in Control of the Company (as defined in the Plan and the applicable award agreement) or upon the death or disability of the Reporting Person, and the shares covered by the RSU are issuable following vesting as provided in the Plan and the applicable award agreement. The RSUs are granted pursuant to the Company's 2009 Equity Incentive Plan (the "Plan") and are subject to other provisions in the applicable award agreement.